Medical/Pharmaceuticals

Cambrex Announces New Liquid-Phase Peptide Synthesis Manufacturing Technology

EAST RUTHERFORD, N.J., Sept. 19, 2024 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced that Snapdragon Chemistry, a Cambrex company, has successfully developed a new liquid-phase peptide synthesis (LPPS) technology that utilizes...

2024-09-19 18:00 4467

Sirnaomics Announces Demonstration of a Novel Mechanism of Action of Its siRNA Therapeutics for Focal Fat Reduction in Journal of Cosmetic Dermatology

HONG KONG, GERMANTOWN, Md., and SUZHOU, China, Sept. 19, 2024 /PRNewswire/ -- Sirnaomics Ltd.(the "Company", Stock Code: 2257, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, tod...

2024-09-19 17:28 5389

Fullerton Health Unveils 2023 Sustainability Report, Strengthening Commitment to a Greener Future

SINGAPORE, Sept. 19, 2024 /PRNewswire/ -- Fullerton Health is proud to announce the launch of its 2023 Sustainability Report. Understanding the urgency of the climate agenda, FHG, in the second year of Sustainability reporting, has incorporated a carbon plan. In addition to highlighting the compa...

2024-09-19 16:45 3268

Hyphens Pharma Launches Ceradan® Advanced Hand Balm, Specially Designed for Hand Eczema

SINGAPORE, Sept. 19, 2024 /PRNewswire/ -- Today, Hyphens Pharma International Limited ("Hyphens Pharma", or the "Company", and together with its subsidiaries, the "Group"), Singapore's leading specialty pharmaceutical and consumer healthcare group, is pleased to announce the launch of Ceradan® A...

2024-09-19 14:00 3426

Transcenta Updates Encouraging Efficacy Data from First-line Triple Combo Trial of Osemitamab (TST001) for G/GEJ Cancer at ESMO 2024

Updated results with longer follow-up reveal confirmed ORR of 68% and median PFS of 14.2 months in patients with CLDN18.2 high or medium expression, known PD-L1 CPS (n=66). PRINCETON, N.J. and SUZHOU, China, Sept. 19, 2024 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), ...

2024-09-19 08:00 6668

VISTA 25th Birthday Eye Carnival: A Rockin' Celebration of Vision and 25 Years of Excellence

PETALING JAYA, Malaysia, Sept. 19, 2024 /PRNewswire/ -- Get ready to rock out with VISTA Eye Specialist ('VISTA') as we celebrate our 25th Birthday with the "See The World Like A Rockstar" Eye Carnival! This event embraces the Rockstar theme, embodying our commitment to empowering individuals—emp...

2024-09-19 08:00 2946

Zymo Research Stands by Its Innovative cfDNA Technology in Response to Qiagen's Lawsuit

IRVINE, Calif., Sept. 18, 2024 /PRNewswire/ -- Zymo Research Corporation, a leader in innovative life science solutions, acknowledges the patent infringement lawsuit filed by Qiagen GmbH onAugust 20, 2024, at the US District Court for the Central District ofCalifornia regarding its MAGicBead cfDN...

2024-09-18 22:00 2106

OM1 Earns Frost & Sullivan's 2024 North American New Product Innovation Award for Transforming Real-world Evidence Analytics Solutions Industry with Its Pioneering AI-powered Platforms

OM1's innovative solutions, such as Orion, Lyra, and Polaris, are revolutionizing patient journey analysis and clinical research through deep AI integration and highly personalized insights. SAN ANTONIO, Sept. 18, 2024 /PRNewswire/ -- Frost & Sullivan recently researched the real-world evidence ...

2024-09-18 22:00 2341

Kintara Therapeutics Reminds Stockholders to Vote by Thursday to Allow for Completion of the Proposed Merger with TuHURA Biosciences

* Stockholders must vote by 11:59 p.m. ET on September 19, 2024 for their vote to count * A "FOR" vote on Proposals 3 & 5 by holders of a majority of the voting power of Kintara's outstanding shares as ofAugust 14, 2024 is required to allow for completion the proposed merger with TuHURA Biosc...

2024-09-18 20:30 5037

Prof. Gang Shen Presents Smartee S8 Orthopedic Therapy at ACAS Sydney

SYDNEY, Sept. 18, 2024 /PRNewswire/ -- The Australian Clear Aligner Society (ACAS) recently brought together top orthodontic experts worldwide. Among the distinguished speakers was Smartee Chief Scientist, Prof. Gang Shen, who delivered an insightful presentation titled "The Clear S8 Orthopedic T...

2024-09-18 20:16 3619

Frost & Sullivan grants the Global Medical Imaging Foundation Model Innovation Award to Hangzhou Diagens Biotechnology Co.,Ltd.

SHANGHAI, Sept. 18, 2024 /PRNewswire/ -- Frost & Sullivan is pleased to announce that the 18th Growth Innovation Leadership (GIL) Summit and the 3rd New Investment Event (NIE 2024), was held inShanghai from August 27 to 30, 2024 , co-hosted by LeadLeo. Based on the research and analysis of the gl...

2024-09-18 16:16 2414

TVM Capital Healthcare Announces Investment in Human Longevity, Inc. as Part of its Strategy of Supporting Disease Prevention and Healthy Aging

HLI is one of the most established, global longevity science companies and committed to accelerating living to 100+ years of a healthy, active, and mobile life DUBAI, UAE and RIYADH, Saudi Arabia, Sept. 18, 2024 /PRNewswire/ -- TVM Capital Healthcare, an international healthcare expansion a...

2024-09-18 16:00 1963

Clarivate Announces 15th Annual Pharmavision India Conference Agenda

Industry leaders to discuss AI in healthcare, cell and gene therapy, market access and more at premier life sciences event LONDON, Sept. 18, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced the full agenda for the 15th annua...

2024-09-18 15:00 2949

Epitomee Medical Announces FDA Clearance of its Capsule, Weight Management Device

Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise. CAESAREA, Israel, Sept. 17, 2024 /PRNewswire/ -- Epitomee Medical Ltd.

2024-09-18 09:00 3322

BioDuro-Sundia Appoints Dr. Armin Spura as New Chief Executive Officer

SHANGHAI, Sept. 18, 2024 /PRNewswire/ -- BioDuro-Sundia, a leading Contract Research, Development, and Manufacturing Organization (CRDMO), is pleased to announce the appointment of Dr.Armin Spura as its new Chief Executive Officer. Dr. Spura brings over two decades of experience in the life scien...

2024-09-18 08:30 3832

Innovent Delivers Oral Presentations on Clinical Data of IBI354 (HER2 Monoclonal Antibody-Camptothecin Derivative Conjugate) in Advanced Ovarian Cancer, Breast Cancer and Other Solid Tumors at the 2024 ESMO Congress

SAN FRANCISCO and SUZHOU, China, Sept. 18, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabol...

2024-09-18 08:00 4830

Innovent Announces Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) Combined with Bevacizumab in Advanced Colorectal Cancer at the 2024 ESMO Congress

SAN FRANCISCO and SUZHOU, China, Sept. 18, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metaboli...

2024-09-18 08:00 4793

MedAdvisor Solutions Launches Pharmacy Advisory Group to Empower and Expand the Role of the Pharmacist

Industry leaders collaborate to bring innovative approaches to evolving pharmacy needs CAMBERWELL, Australia, Sept. 18, 2024 /PRNewswire/ -- MedAdvisor Solutions, a global leader in pharmacy-driven patient engagement solutions, announced today the launch of its Pharmacy Advisory Group. The colla...

2024-09-18 06:00 3272

Telix Announces Cardinal Health as U.S. Commercial Distributor for Zircaix®

MELBOURNE, Australia, Sept. 18, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has selected Cardinal Health, Inc. (NYSE: CAH, Cardinal Health) as a commercial radiopharmaceutical distributor to supply finished unit doses of its PET[1] ag...

2024-09-18 05:00 2713

Zoetis to Introduce First Cartridge-Based AI-Powered Haematology Analyser

* Zoetis is introducing Vetscan® OptiCell™ to Australia as it continues to transform diagnostics with its suite of integrated products and services * The new haematology analyser offers innovative AI-powered technology for CBC analysis, providing lab quality accuracy1 at the point of care * ...

2024-09-17 21:00 2734
1 ... 148149150151152153154 ... 380